GB2090249B - Fused-ring pyrimidones - Google Patents

Fused-ring pyrimidones

Info

Publication number
GB2090249B
GB2090249B GB8137458A GB8137458A GB2090249B GB 2090249 B GB2090249 B GB 2090249B GB 8137458 A GB8137458 A GB 8137458A GB 8137458 A GB8137458 A GB 8137458A GB 2090249 B GB2090249 B GB 2090249B
Authority
GB
United Kingdom
Prior art keywords
pyrimidones
fused
ring
ring pyrimidones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8137458A
Other languages
English (en)
Other versions
GB2090249A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB2090249A publication Critical patent/GB2090249A/en
Application granted granted Critical
Publication of GB2090249B publication Critical patent/GB2090249B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
GB8137458A 1980-12-12 1981-12-11 Fused-ring pyrimidones Expired GB2090249B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
GB2090249A GB2090249A (en) 1982-07-07
GB2090249B true GB2090249B (en) 1984-08-22

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8137458A Expired GB2090249B (en) 1980-12-12 1981-12-11 Fused-ring pyrimidones

Country Status (22)

Country Link
US (1) US4379788A (enExample)
EP (1) EP0054132B1 (enExample)
AR (1) AR227567A1 (enExample)
AU (1) AU543568B2 (enExample)
CA (1) CA1217767A (enExample)
CS (1) CS227024B2 (enExample)
DD (1) DD208151A5 (enExample)
DE (1) DE3166627D1 (enExample)
DK (1) DK525481A (enExample)
ES (2) ES8207156A1 (enExample)
FI (1) FI813971A7 (enExample)
GB (1) GB2090249B (enExample)
GR (1) GR76952B (enExample)
HU (1) HU187384B (enExample)
IL (1) IL64504A (enExample)
MY (1) MY8700562A (enExample)
NO (1) NO814239L (enExample)
NZ (1) NZ199254A (enExample)
PH (1) PH18930A (enExample)
PL (1) PL135330B1 (enExample)
PT (1) PT74116B (enExample)
SU (1) SU1056900A3 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
WO1999024433A1 (de) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
RU2207337C2 (ru) * 1998-11-18 2003-06-27 Изаксон Елена Александровна 6-(3-ацетилфенил)аминоурацил
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
AU2002257195A1 (en) * 2001-04-23 2002-11-05 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
MXPA03010119A (es) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas 2-fenilo sustituidas.
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1696927A4 (en) * 2003-12-19 2007-10-31 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
EP1757594A4 (en) * 2004-05-31 2007-12-12 Banyu Pharma Co Ltd quinazoline derivative
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
MX2009003673A (es) * 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
EP2273882A4 (en) * 2008-05-13 2011-07-13 Poniard Pharmaceuticals Inc BIOACTIVE COMPOUNDS FOR THE TREATMENT OF CANCER AND NEURODEEGENERATIVE DISEASES
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
BR112015006524A8 (pt) * 2012-09-26 2019-08-20 Merck Patent Gmbh derivados de quinazolinona como inibidores de parp, seu processo de preparação, seu uso, medicamentos e conjunto (kit)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
HU187384B (en) 1985-12-28
ES507761A0 (es) 1982-09-01
EP0054132B1 (de) 1984-10-10
DK525481A (da) 1982-06-13
ES8207156A1 (es) 1982-09-01
SU1056900A3 (ru) 1983-11-23
PL135330B1 (en) 1985-10-31
DE3166627D1 (en) 1984-11-15
US4379788A (en) 1983-04-12
PT74116B (de) 1983-12-19
FI813971L (fi) 1982-06-13
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
NO814239L (no) 1982-06-14
PT74116A (de) 1982-01-01
PL234175A1 (enExample) 1982-08-16
IL64504A (en) 1985-02-28
CS227024B2 (en) 1984-04-16
PH18930A (en) 1985-11-11
FI813971A7 (fi) 1982-06-13
MY8700562A (en) 1987-12-31
DD208151A5 (de) 1984-03-28
NZ199254A (en) 1985-02-28
GR76952B (enExample) 1984-09-04
AU7847381A (en) 1982-06-17
IL64504A0 (en) 1982-03-31
EP0054132A1 (de) 1982-06-23
AU543568B2 (en) 1985-04-26
CA1217767A (en) 1987-02-10
ES8304096A1 (es) 1983-02-16
AR227567A1 (es) 1982-11-15

Similar Documents

Publication Publication Date Title
GB2090249B (en) Fused-ring pyrimidones
GB2091724B (en) Sulpho-oxoazetidines
JPS57108150A (en) Stable epoxy dispersion
CS23281A2 (en) Zpusob vyroby novych retardovanych forem dipyridamolu
PH22654A (en) Substituted pyrimidine
JPS5718681A (en) Novel triazoloquinoxalin-4-one
ZA813564B (en) Novel arylphenylacetylene compounds
CS714981A2 (en) Ridici zarizeni pro trysky tkalcovskeho stroje se zanasenim paprskem vzduchu
GB2089792B (en) Substituted benzopyranotriazoles
JPS57123170A (en) Novel pyrimidone compound
CS193681A1 (en) Dalkove ovladany regulacni sroub barvicich zarizeni v zasobnicich barev tiskovych stroju
CS198081A2 (en) Herbicidni prostredek
CS862781A2 (en) Pomocna dmychaci tryska pro proslup tkalcovskeho stroje se vzduchovym paprskem
GB2093456B (en) 1-r1-3-phenozyazetidines
JPS5767500A (en) Scissors-lift
ZA816635B (en) Novel 2-aminoimidazoles
JPS57158753A (en) Novel bicyclooxyphenylurea
JPS56161374A (en) Novel imidodisulfamide
AU2155983A (en) Heteroalkylthioalkylamino substituted pyrimidones
CS233381A1 (en) Kancelarsky dirkovac skladne konstrukce
JPS56140956A (en) Novel ortho-alkoxy substituted 2-haloacetanilide
PH18438A (en) Novel sulfinylamides
JPS56128741A (en) Novel o-aminoalkylsalicylate
ZA816753B (en) Novel sulfenyls
IE801689L (en) Substituted trichloropropylureas

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee